Im Focus Onkologie

, Volume 21, Issue 5, pp 72–77 | Cite as

S3-Leitlinie „Supportive Therapie bei onkologischen PatientInnen“

Supportive Maßnahmen in der Radioonkologie

Supportivtherapie Fortbildung

Unter einer Bestrahlung können akute, aber auch späte Nebenwirkungen auftreten. Einige lassen sich aber wirksam vermeiden oder gut behandeln. Dabei ist die interdisziplinäre Kommunikation entscheidend — vor, während und nach der Bestrahlung.

Literatur

  1. 1.
    S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen. Langversion 1.0 — November 2016. AWMF-Registernummer: 032/054OL.Google Scholar
  2. 2.
    Kiliç D et al. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol. 2000;57(2):125–9.CrossRefGoogle Scholar
  3. 3.
    Westbury C et al. Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol. 2000;54(2):109–16.CrossRefGoogle Scholar
  4. 4.
    Höller U et al. [Osteoradionecrosis after radiotherapy for gynecologic tumors]. Strahlenther Onkol. 2001;177(6):291–5.CrossRefGoogle Scholar
  5. 5.
    Heyboer M 3rd et al. Hyperbaric oxygen and dental extractions in irradiated patients: short- and long-term outcomes. Undersea Hyperb Med. 2013;40(3):283–8.PubMedGoogle Scholar
  6. 6.
    Grötz KA; Strahlenther Onkol. 2003 Apr;179(4):275-8. [Dental care for patients with antineoplastic radiotherapy of the head and neck]. [Article in German]. Grötz KA; Gemeinsame Stellungnahme der DGZMK und der DEGRO in Abstimmung mit dem Vorstand der DGZ. [Dental care for patients with antineoplastic radiotherapy of the head and neck]. Strahlenther Onkol. 2003;179(4):275–8.PubMedGoogle Scholar
  7. 7.
    McGuire DB et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3165–77.CrossRefGoogle Scholar
  8. 8.
    Lalla RV et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.CrossRefGoogle Scholar
  9. 9.
    Horiot JC et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000;55(3):233–9.CrossRefGoogle Scholar
  10. 10.
    Milano MT et al. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008;3:36.CrossRefGoogle Scholar
  11. 11.
    Antonadou D et al. Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 2001;51(4):915–22.CrossRefGoogle Scholar
  12. 12.
    Aapro M et al. MASCC/ESMO ANTIEMETIC GUIDELINE 2016. http://www.mascc.org/antiemetic-guidelines.
  13. 13.
    Levin VA et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487–95.CrossRefGoogle Scholar
  14. 14.
    Kirste S et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011;117(16):3788–95.CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.RecklinghausenDeutschland
  2. 2.

Personalised recommendations